First author & publication year | Country, design & funding | Outcome definition | Inclusion (1) & exclusion (2) criteria | Study size | Sample size calculation and power | Comparable at baseline | Adequate random sequence generation | Adequate allocation concealment | Adequate blinding | Adequate follow-up | Attrition, % (range) | ITT data |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Wilkes, 2013 [41] | USA, cluster RCT, non-profit | Primary & Secondary | 1 | N ≥ 200 | yes | yes | unclear | yes | HCP: yes Participants: yes OA: unclear | noa | ≤20% (0–20%) | yesb |
Landrey, 2013 [42] | USA, parallel RCT, non-profit | Primary & Secondary | 1, 2 | N ≥ 200 | nr | yes | unclear | nr | HCP: nr Participants: nr OA: yes | yes | ≥20% (6.60–51.16%) | no |
USA, parallel RCT, non-profit | Primary & Secondary | 1, 2 | N ≥ 200 | nr | Partialc | yes | yes | HCP: no Participants: nr OA: unclear | yes | < 20% (0–13.29%)d | yesb | |
Gatellari, 2003 [45] | Australia, parallel RCT, non-profit | Primary | 1 | N ≥ 200 | ire | yes | yes | yes | HCP: yes Participants: yes OA: unclear | yes | ≥20% (13.71–27.82%) | no |